Global Atropine Sulfate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Atropine Sulfate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Atropine Sulfate is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings.
Atropine Sulfate report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Atropine Sulfate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Gastrointestinal and Ophthalmology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Atropine Sulfate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Atropine Sulfate key manufacturers include C2PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng, CR Double-Crane, HENAN PURUI, Albany Molecular Research, Alchem International and SAURAV CHEMICALS, etc. C2PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING are top 3 players and held % sales share in total in 2022.
Atropine Sulfate can be divided into Injection, Drop and Gel,, etc. Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Atropine Sulfate is widely used in various fields, such as Gastrointestinal, Ophthalmology and Other,, etc. Gastrointestinal provides greatest supports to the Atropine Sulfate industry development. In 2022, global % sales of Atropine Sulfate went into Gastrointestinal filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Atropine Sulfate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
C2PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century
Segment by Type
Injection
Drop
Gel
Gastrointestinal
Ophthalmology
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Atropine Sulfate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Atropine Sulfate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Atropine Sulfate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Atropine Sulfate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Atropine Sulfate introduction, etc. Atropine Sulfate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Atropine Sulfate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Atropine Sulfate report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Atropine Sulfate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Gastrointestinal and Ophthalmology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Atropine Sulfate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Atropine Sulfate key manufacturers include C2PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng, CR Double-Crane, HENAN PURUI, Albany Molecular Research, Alchem International and SAURAV CHEMICALS, etc. C2PHARMA, RESONANCE LABORATORIES, ROLABO OUTSOURCING are top 3 players and held % sales share in total in 2022.
Atropine Sulfate can be divided into Injection, Drop and Gel,, etc. Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Atropine Sulfate is widely used in various fields, such as Gastrointestinal, Ophthalmology and Other,, etc. Gastrointestinal provides greatest supports to the Atropine Sulfate industry development. In 2022, global % sales of Atropine Sulfate went into Gastrointestinal filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Atropine Sulfate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
C2PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century
Segment by Type
Injection
Drop
Gel
Segment by Application
Gastrointestinal
Ophthalmology
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Atropine Sulfate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Atropine Sulfate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Atropine Sulfate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Atropine Sulfate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Atropine Sulfate introduction, etc. Atropine Sulfate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Atropine Sulfate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices